A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 956,000 shares of TEVA stock, worth $15.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
956,000
Previous 1,514,006 36.86%
Holding current value
$15.5 Million
Previous $15.8 Million 14.66%
% of portfolio
0.03%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $5.95 Million - $8.05 Million
-558,006 Reduced 36.86%
956,000 $13.5 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $951,590 - $1.25 Million
-117,191 Reduced 7.18%
1,514,006 $15.8 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $5.16 Million - $7.38 Million
689,739 Added 73.26%
1,631,197 $16.6 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $6.78 Million - $8.92 Million
941,399 Added 1595591.5%
941,458 $7.09 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $493 - $670
59 New
59 $0
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $40 Million - $56.4 Million
5,424,079 Added 441.02%
6,653,979 $50 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $9.02 Million - $11.5 Million
1,229,900 New
1,229,900 $11.5 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $15.5 Million - $18.1 Million
-1,568,700 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $16.2 Million - $20.1 Million
1,568,700 New
1,568,700 $18.1 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $1.56 Million - $2 Million
-180,714 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $1.55 Million - $2.29 Million
180,714 New
180,714 $1.63 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $178,980 - $293,824
-27,409 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$6.16 - $9.6 $89,437 - $139,382
14,519 Added 112.64%
27,409 $189,000
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $78,747 - $152,452
9,698 Added 303.82%
12,890 $119,000
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $49,731 - $63,871
3,192 New
3,192 $50,000
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $6.04 Million - $9.87 Million
-414,100 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $69.9 Million - $85.1 Million
-3,317,214 Reduced 88.9%
414,100 $8.92 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $62.6 Million - $92.2 Million
3,731,314 New
3,731,314 $90.7 Million
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $5.47 Million - $7.23 Million
-327,650 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $2.28 Million - $3.87 Million
202,650 Added 162.12%
327,650 $6.21 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $1.93 Million - $4.02 Million
125,000
125,000 $2.2 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.